Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.37 |
| ▸ | KDM4A | O75164 | 1/20 | 0.37 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.37 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.37 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.36 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.36 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.36 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.36 |
| ▸ | RARB | P10826 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | FUT7 | Q11130 | 1/20 | 0.33 |
| ▸ | GABRP | O00591 | 2/20 | 0.32 |
| ▸ | GABRD | O14764 | 2/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.32 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.32 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.32 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29504074 | 1.00 | KDM4C (0.37) | KDM4CKDM4APHF8KDM2AGRIN2D | |
| SCHEMBL29504083 | 1.00 | KDM4C (0.37) | KDM4CKDM4APHF8KDM2AGRIN2D | |
| SCHEMBL29504080 | 1.00 | KDM4C (0.37) | KDM4CKDM4APHF8KDM2AGRIN2D | |
| SCHEMBL31389356 | 1.00 | KDM4C (0.37) | KDM4CKDM4APHF8KDM2AGRIN2D | |
| SCHEMBL745611 | 1.00 | KDM4C (0.37) | KDM4CKDM4APHF8KDM2AGRIN2D | |
| SCHEMBL29504105 | 1.00 | KDM4C (0.37) | KDM4CKDM4APHF8KDM2AGRIN2D | |
| SCHEMBL1121901 | 1.00 | KDM4C (0.37) | KDM4CKDM4APHF8KDM2AGRIN2D | |
| SCHEMBL14989332 | 1.00 | KDM4C (0.37) | KDM4CKDM4APHF8KDM2AGRIN2D | |
| SCHEMBL14989198 | 1.00 | KDM4C (0.37) | KDM4CKDM4APHF8KDM2AGRIN2D | |
| SCHEMBL29430235 | 1.00 | KDM4C (0.37) | KDM4CKDM4APHF8KDM2AGRIN2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4735513-A1 | LOW-EMISSION POLYMER COMPOSITIONS | TMG - Tecidos Plastificados e Outros Revestimentos para a Indústria Automóvel, S.A. (PT) | 2026-05-06 | — | — | EP | disclosed |
| US-12586817-B2 | Polysulfide-polyoxide electrolyte membrane for energy storage device | THE UNIVERSITY OF AKRON (US) | 2026-03-24 | — | — | US | disclosed |
| WO-2025002665-A1 | LOW-EMISSION POLYMER COMPOSITIONS | TMG - TECIDOS PLASTIFICADOS E OUTROS REVESTIMENTOS PARA A INDÚSTRIA, AUTOMÓVEL, S.A. (PT) | 2025-01-02 | — | — | WO | disclosed |
| EP-4484481-A1 | LOW-EMISSION POLYMER COMPOSITIONS | TMG - Tecidos Plastificados e Outros Revestimentos para a Indústria Automóvel, S.A. (PT) | 2025-01-01 | — | — | EP | disclosed |
| EP-4469027-A2 | NOVEL COMPOSITIONS | Tulex Pharmaceuticals Inc. (US) | 2024-12-04 | — | — | EP | disclosed |
| EP-4469031-A1 | LIQUID RESIN EXTENDED-RELEASE ORAL NALTREXONE FORMULATION FOR TREATING AUTISM-RELATED DISORDERS | Aardvark Therapeutics Inc. (US) | 2024-12-04 | — | — | EP | disclosed |
| EP-4467713-A2 | COMPOSITE STRUCTURE CONTAINING A PVC TEXTILE LAYER AND A PVC COVER LAYER | TMG - Tecidos Plastificados e Outros Revestimentos para a Indústria Automóvel, S.A. (PT) | 2024-11-27 | — | — | EP | disclosed |
| US-20240366505-A1 | Liquid Resin Extended-Release Oral Naltrexone Formulation for Treating Autism-Related Disorders | Aardvark Therapeutics, Inc. (US) | 2024-11-07 | — | — | US | disclosed |
| US-20240189875-A1 | SYSTEM AND A METHOD FOR INJECTION MOLDING PVC, ADHESIVE AND PAPER PRODUCTS | AMERICAN RENOLIT CORP (US) | 2024-06-13 | — | — | US | disclosed |
| US-20240128503-A1 | POLYSULFIDE-POLYOXIDE ELECTROLYTE MEMBRANE FOR ENERGY STORAGE DEVICE | NISSAN NORTH AMERICA, INC. | 2024-04-18 | — | — | US | disclosed |
| EP-0574348-B1 | PVC moulding materials stabilized with organotin compounds | CIBA GEIGY AG (CH) | 1998-10-07 | — | — | EP | disclosed |
| EP-0796840-A2 | Stabilisers for polymers containing chlorine | Ciba SC Holding AG (CH) | 1997-09-24 | — | — | EP | disclosed |
| EP-0796888-A2 | Stabiliser composition for polymers containing chlorine | Ciba SC Holding AG (CH) | 1997-09-24 | — | — | EP | disclosed |
| EP-0768336-A2 | Stabiliser combinations for chlorinated polymers | Ciba SC Holding AG (CH) | 1997-04-16 | — | — | EP | disclosed |
| EP-0751180-A1 | Stabilized halogen-containing polymers | Ciba SC Holding AG (CH) | 1997-01-02 | — | — | EP | disclosed |
| EP-0677550-A2 | Stabilised polyvinyl chloride | CIBA-GEIGY AG (CH) | 1995-10-18 | — | — | EP | disclosed |
| EP-0574348-A1 | PVC moulding materials stabilized with organotin compounds | CIBA-GEIGY AG (CH) | 1993-12-15 | — | — | EP | disclosed |
| EP-0374461-B1 | FUELS FOR COMBUSTION MACHINES | BASF Aktiengesellschaft (DE) | 1992-05-13 | — | — | EP | disclosed |
| US-5004478-A | Detergent and oil mixture of modified polyether and ester | BASF AKTIENGESELLSCHAFT (DE) | 1991-04-02 | — | — | US | disclosed |
| EP-0374461-A1 | Fuels for combustion machines | BASF Aktiengesellschaft (DE) | 1990-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12586817-B2 | Polysulfide-polyoxide electrolyte membrane for energy storage device | SLC6A12, SLC6A6, SLC6A5 | KDM4C 3407/4885KDM4A 2703/4885PHF8 2616/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.